Jove
Visualize
联系我们

相关概念视频

Gene Therapy00:59

Gene Therapy

25.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.3K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Heparin-induced thrombocytopenia immune complexes activate the inflammasome pathway in a complement-dependent manner.

Journal of thrombosis and haemostasis : JTH·2026
Same author

The insulin-like peptides Dilp2 and Dilp6 exhibit divergent responses to dietary sugar and protein in <i>Drosophila</i> larvae.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Optogenetic restoration of high-sensitivity vision using ChRmine- and ChroME-based channelrhodopsins.

Scientific reports·2025
Same author

Truncated complement factor H Y402 gene therapy rescues C3 glomerulonephritis.

Molecular therapy : the journal of the American Society of Gene Therapy·2025
Same author

Dopamine D1 receptor activation in the striatum is sufficient to drive reinforcement of anteceding cortical patterns.

Neuron·2025
Same author

Synchronizing Drosophila larvae with the salivary gland reporter Sgs3-GFP for discovery of phenotypes in the late third instar stage.

Developmental biology·2024
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: Jun 11, 2025

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

17.7K

截断的补充因子 H Y402 基因疗法 治愈 C3 淋巴结膜炎

Lindsey A Chew1,2, Daniel Grigsby3, C Garren Hester1

  • 1Department of Ophthalmology, Duke Eye Center, Duke University Medical Center, Durham, NC 27710.

bioRxiv : the preprint server for biology
|September 30, 2024
PubMed
概括

腺相关病毒输送截断的补充因子H (tCFH) 有效地逆转了小鼠的C3球球腺炎. 这种基因疗法方法对治疗C3G和与年龄相关的黄斑变性很有前途.

关键词:
在C3型球体隆炎中.在C3型淋巴细胞病变中.与年龄相关的黄斑变性.补充因子 H 是 H 的补充因子.补充法规补充法规的规定.基因替代是一种基因替代.基因治疗的基因疗法

更多相关视频

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
09:37

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

8.2K
Constitutive and Inducible Systems for Genetic In Vivo Modification of Mouse Hepatocytes Using Hydrodynamic Tail Vein Injection
09:35

Constitutive and Inducible Systems for Genetic In Vivo Modification of Mouse Hepatocytes Using Hydrodynamic Tail Vein Injection

Published on: February 2, 2018

14.1K

相关实验视频

Last Updated: Jun 11, 2025

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

17.7K
A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
09:37

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

8.2K
Constitutive and Inducible Systems for Genetic In Vivo Modification of Mouse Hepatocytes Using Hydrodynamic Tail Vein Injection
09:35

Constitutive and Inducible Systems for Genetic In Vivo Modification of Mouse Hepatocytes Using Hydrodynamic Tail Vein Injection

Published on: February 2, 2018

14.1K

科学领域:

  • 眼科医生 眼科 眼科
  • 腎臟病學 (nephrology) 是一種醫學專業.
  • 基因治疗 基因治疗

背景情况:

  • 与年龄相关的黄斑变性 (AMD) 和C3型血球膜炎 (C3G) 分享补充失调的途径.
  • 目前对C3G的治疗方法有限,以前使用外源补充因子H (CFH) 的尝试面临免疫排斥.
  • C3G的特点是补充替代途径失调.

研究的目的:

  • 为了研究由腺相关病毒 (AAV) 介导的截断CFH (tCFH) 的传递,用于治疗C3G.
  • 在小鼠模型中评估AAV-tCFH基因治疗的疗效和长期安全性.
  • 探索AAV-tCFH作为C3G和AMD的潜在治疗方法.

主要方法:

  • 使用了C3G.的Cfh/-鼠标模型.
  • 使用各种编码截断补充因子H (tCFH) 的腺相关病毒 (AAV) 载体.
  • 监测补充通路抑制,疾病逆转和免疫反应.

主要成果:

  • 长期的AAV介导的tCFH输送成功抑制了补充替代途径.
  • 在没有免疫排斥的证据的情况下实现了C3G的逆转.
  • 不同的AAV载体表现出不同程度的效率和疗效.

结论:

  • 以AAV为媒介的tCFH基因疗法为C3G治疗提供了一个有前途的策略,克服了以前方法的局限性.
  • 这项研究为AMD的AAV-tCFH基因增强疗法提供了概念证明.
  • 这些发现支持开发针对C3G和AMD患者补体失调的新型基因疗法.